INOVIO PHARMACEUTICALS, INC. (Nasdaq:INO)

Health Care/Life Sciences • Biotechnology

CIK 1055726

Company

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Address
660 West Germantown Pike
Suite 110
Plymouth Meeting, Pennsylvania 19462-1111

Employees
122

Stock Info

Close
$1.9700

Day Range
1.9100 - 2.0000

52 Week Range
1.7400 - 14.7480

Average volume
1.05M

Short Interest
5.38M (02/14/25)

% of Float Shorted
15.02%

Market Cap
$71.12M

Revenue
$832.01K

Net Income
-$135.12M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$4.4847

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Jacqueline E. Shea

Director
David B. Weiner

Chairman
Simon X. Benito

Independent Director
Roger D. Dansey

Independent Director
Jay P. Shepard

Independent Director
Lota S. Zoth

Independent Director
Wendy L. Yarno

Independent Director
Ann Calby Miller

SEC filings

Date	Form	Event
18 Dec, 2024	4
16 Dec, 2024	8-K
13 Dec, 2024	424B5
12 Dec, 2024	424B5
14 Nov, 2024	10-Q
14 Nov, 2024	8-K
8 Nov, 2024	SC 13G
22 Oct, 2024	SC 13G
13 Aug, 2024	424B5
13 Aug, 2024	8-K
8 Aug, 2024	8-K
8 Aug, 2024	10-Q
1 Jul, 2024	4
28 May, 2024	8-K
22 May, 2024	4
22 May, 2024	4
22 May, 2024	4
22 May, 2024	4
22 May, 2024	4
22 May, 2024	4
22 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
16 May, 2024	4
13 May, 2024	10-Q
13 May, 2024	4
13 May, 2024	4
13 May, 2024	8-K
26 Apr, 2024	SC 13G
17 Apr, 2024	8-K
17 Apr, 2024	424B5
15 Apr, 2024	ARS
11 Apr, 2024	DEF 14A
6 Mar, 2024	10-K
28 Feb, 2024	4
28 Feb, 2024	4
28 Feb, 2024	4
28 Feb, 2024	4
28 Feb, 2024	4
13 Feb, 2024	SC 13G/A
31 Jan, 2024	EFFECT
29 Jan, 2024	CORRESP
26 Jan, 2024	S-3/A
25 Jan, 2024	8-K
22 Jan, 2024	SC 13G/A
12 Jan, 2024	8-K
28 Nov, 2023	DEF 14A
17 Nov, 2023	PRE 14A
16 Nov, 2023	UPLOAD
9 Nov, 2023	S-3
9 Nov, 2023	8-K
9 Nov, 2023	10-Q
2 Nov, 2023	8-K
10 Oct, 2023	8-K
9 Aug, 2023	8-K
9 Aug, 2023	10-Q
1 Aug, 2023	8-K
10 Jul, 2023	SC 13G/A
7 Jul, 2023	SC 13G/A
3 Jul, 2023	4
23 Jun, 2023	8-K
5 Jun, 2023	4
5 Jun, 2023	144
18 May, 2023	8-K
18 May, 2023	S-8
18 May, 2023	S-8
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
17 May, 2023	4
16 May, 2023	4
16 May, 2023	4
16 May, 2023	4
16 May, 2023	4
16 May, 2023	4
16 May, 2023	4
16 May, 2023	4
12 May, 2023	4
10 May, 2023	8-K
10 May, 2023	10-Q
3 Apr, 2023	EFFECT
31 Mar, 2023	DEFA14A
28 Mar, 2023	ARS
28 Mar, 2023	POS EX
28 Mar, 2023	DEF 14A
13 Mar, 2023	4
13 Mar, 2023	4
13 Mar, 2023	4
13 Mar, 2023	4
1 Mar, 2023	POS AM
1 Mar, 2023	10-K
1 Mar, 2023	8-K
1 Mar, 2023	POSASR
28 Feb, 2023	4
28 Feb, 2023	4
28 Feb, 2023	4
28 Feb, 2023	4
28 Feb, 2023	4
9 Feb, 2023	SC 13G/A
9 Feb, 2023	SC 13G/A
31 Jan, 2023	8-K
24 Jan, 2023	SC 13G/A
17 Jan, 2023	4
8 Nov, 2022	10-Q
8 Nov, 2022	8-K
14 Oct, 2022	UPLOAD
29 Sep, 2022	CORRESP
15 Sep, 2022	UPLOAD
11 Aug, 2022	4
9 Aug, 2022	10-Q
9 Aug, 2022	8-K
20 Jul, 2022	4
19 Jul, 2022	8-K
6 Jul, 2022	4
6 Jul, 2022	3
30 Jun, 2022	S-8
17 May, 2022	4
17 May, 2022	4
17 May, 2022	4
17 May, 2022	4
17 May, 2022	4
17 May, 2022	8-K	CEO Change
17 May, 2022	4
17 May, 2022	4
11 May, 2022	DEFA14A
11 May, 2022	4
10 May, 2022	10-Q
10 May, 2022	8-K	CEO Change
11 Apr, 2022	SC 13G/A
28 Mar, 2022	4
25 Mar, 2022	DEF 14A
22 Mar, 2022	4
17 Mar, 2022	4
14 Mar, 2022	4
14 Mar, 2022	4
14 Mar, 2022	4
14 Mar, 2022	4
14 Mar, 2022	4
14 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
1 Mar, 2022	10-K
1 Mar, 2022	4
1 Mar, 2022	4
1 Mar, 2022	4
1 Mar, 2022	S-8
1 Mar, 2022	4
1 Mar, 2022	4
11 Feb, 2022	SC 13G/A
10 Feb, 2022	SC 13G/A
1 Feb, 2022	SC 13G/A
21 Jan, 2022	4
18 Jan, 2022	4
5 Jan, 2022	4
9 Nov, 2021	424B5
9 Nov, 2021	10-Q
29 Oct, 2021	8-K
28 Oct, 2021	8-K
11 Aug, 2021	4
9 Aug, 2021	10-Q
11 Jun, 2021	4
11 Jun, 2021	4
11 Jun, 2021	4
11 Jun, 2021	8-K
4 Jun, 2021	4
17 May, 2021	3
17 May, 2021	8-K
17 May, 2021	4
17 May, 2021	4
17 May, 2021	4
17 May, 2021	4
17 May, 2021	4
17 May, 2021	4
17 May, 2021	4
10 May, 2021	10-Q
21 Apr, 2021	4
21 Apr, 2021	4
16 Apr, 2021	4
26 Mar, 2021	4
25 Mar, 2021	DEF 14A
23 Mar, 2021	4
16 Mar, 2021	4
12 Mar, 2021	4
12 Mar, 2021	4
12 Mar, 2021	4
12 Mar, 2021	4
12 Mar, 2021	4
9 Mar, 2021	4
9 Mar, 2021	4
9 Mar, 2021	4
9 Mar, 2021	4
1 Mar, 2021	8-K
1 Mar, 2021	S-8
1 Mar, 2021	10-K
26 Feb, 2021	4
26 Feb, 2021	4
26 Feb, 2021	4
26 Feb, 2021	4
26 Feb, 2021	4
18 Feb, 2021	4
11 Feb, 2021	SC 13G/A
11 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G
5 Feb, 2021	SC 13G/A
3 Feb, 2021	4
3 Feb, 2021	4
29 Jan, 2021	4
29 Jan, 2021	SC 13G/A
22 Jan, 2021	424B5
22 Jan, 2021	8-K
20 Jan, 2021	S-3ASR
20 Jan, 2021	424B5
20 Jan, 2021	8-K
15 Jan, 2021	4
15 Jan, 2021	4
5 Jan, 2021	4
5 Jan, 2021	4
4 Jan, 2021	8-K

Last update:2025-03-06 12:52:58.565341

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.